Home » FDA Panel Backs Rheumatoid-Arthritis Drug
FDA Panel Backs Rheumatoid-Arthritis Drug
A panel of medical experts backed Roche Holding AG's rheumatoid arthritis drug Actemra, despite safety concerns about how the treatment will affect the liver.
WSJ.com
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May